30
Jan
2019

Finding a Way in Genomic Diagnostics: Bonnie Anderson of Veracyte on The Long Run

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Looking at Cancer From a Different Angle: Pearl Huang on The Long Run
Small Molecules Against RNA Targets: Jennifer Petter on The Long Run
Becoming a Biotech VC: Otello Stampacchia on The Long Run
From Rio to Rome: Rosana Kapeller on The Long Run